Dunhill Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16K | Sell |
4
-4
| -50% | -$2.16K | ﹤0.01% | 671 |
|
|
2025
Q1 | $4.9K | Sell |
8
-367
| -98% | -$225K | ﹤0.01% | 566 |
|
|
2024
Q4 | $267K | Buy |
375
+241
| +180% | +$172K | 0.12% | 69 |
|
|
2024
Q3 | $141K | Buy |
134
+10
| +8% | +$10.5K | 0.07% | 98 |
|
|
2024
Q2 | $130K | Buy |
124
+112
| +933% | +$117K | 0.08% | 92 |
|
|
2024
Q1 | $11.2K | Buy |
12
+2
| +20% | +$1.86K | 0.01% | 219 |
|
|
2023
Q4 | $8.84K | Buy |
+10
| New | +$8.84K | 0.01% | 222 |
|